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In dog thyroid slices prelabeled with myo-[2-3H]inositol, carbachol (10-7-10-4 M) and NaF (l&20 mM) 
stimulated IP,, IP2 and IP3 generation. These effects did not require the presence of extracellular calcium. 
Atropine and PDBu inhibited the action of the cholinergic agonist. No effect of TSH (l-100 mu/ml) could 
be detected on PIP1 hydrolysis and IP production. These results suggest that (i) IP3 could play a role in 
the metabolic actions of carbachol in the thyroid; (ii) a G-protein coupling the hormone-receptor binding 
to phospholipase C activation exists in the thyroid membrane; (iii) the well known TSH-induced increased 
PI turnover does not result in IPs accumulation. 
Inositol phosphate; Carbamylcholine; Sodium fluoride; Thyrotropin; Phorbol ester; (Thyroid) 
1. INTRODUCTION 
Recent work has demonstrated the presence of 
the IP3-DAG second messenger system and of the 
regulated phospholipase C hydrolyzing their mem- 
brane precursor PIP2 in many tissues [l-3]. Ins 
1,4,5-P appears to release Ca2+ from non- 
mitochondrial intracellular sources [4-61. DAG 
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and its phorbol ester analogues on the other hand 
activate a calcium- and phospholipid-dependent 
protein kinase [3,7,8]. 
In the thyroid gland, TSH exerts many of its 
metabolic effects through activation of the 
adenylate cyclase [9-121 but also increases PI 
turnover independently of CAMP accumulation 
[13-181. Cchol similarly stimulates PI turnover in 
the dog thyroid [17,19] and raises [Ca2+]i n dog 
thyroid cells [20,21]. The precise modification of 
thyroid phosphoinositide metabolism occurring in 
these conditions is unknown. This work constitutes 
the first report examining the production of 
inositol phosphates in thyroid tissue exposed to 
TSH and Cchol. 
2. MATERIALS AND METHODS 
2.1. Products 
myo-[2-3H]Inositol (16.5 Ci/mmol) and myo- 
[2-3H]inositol phosphate (8.4 Ci/mmol) were pur- 
chased from New England Nuclear (DuPont-NEN, 
Haren, Belgium), myo-[2-14C]inositol phosphate 
(50-60 Ci/mmol) from the Radiochemical Centre 
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(Amersham, England). Cchol was provided by K 
and K (Plain View, NY, USA), TSH (Thytropar) 
by Armour Pharmaceutical (Chicago, IL, USA) 
and PDBu by Sigma (St. Louis, MO, USA). The 
Dowex AGl-X8 ion-exchange resin (formate form, 
100-200 mesh) was obtained from Bio-Rad (Wat- 
ford, England). Ins-l [4,5-32P]-trisphosphate (spec. 
act. 9000 cpm/nmol) was prepared from human 
erythrocytes by the methods of Downes et al. [22] 
as modified by Irvine et al. [23]. All other reagents 
were of the purest grade commercially available. 
2.2. Tissue preparation and incubation 
Dog thyroid slices were incubated at 37°C under 
an atmosphere of 02/CO2 (95 : 5, v/v) in 2 ml of 
Krebs-Ringer-bicarbonate buffer supplemented 
with 8 mM glucose and 0.5 g/l of bovine serum 
albumin [9]. The slices were first preincubated for 
4 h in the presence of 20,&/ml of [3H]inositol 
(spec. act. 16.5 Cilmmol), then transferred to 
fresh unlabeled incubation medium. After 1.5 min, 
LiCl was added to the incubation flasks (final con- 
centration IO mM), followed after 5 min by the ex- 
perimental agent to be tested for various lengths of 
time. 
2.3. Extraction and separation of ~~Jinosito~ 
phosphates 
Incubation was stopped by rapid immersion and 
IPI 
homogenization of the slices in 2 ml of ice-cold 3% 
HCl04. The homogenate was centrifuged, and the 
resulting pellet washed once with 1% HCl04. The 
combined supernatants were neutralized to pH 
7.7-7.8 by addition of 0.38 M Hepes and 0.76 M 
KOH. After potassium perchlorate precipitation, 
the supernatant was treated and applied to 
AGI-X8 columns (0.6 x 4 cm) [24]. Ins, GPI, IPI, 
IP2 and IP3 were eluted in a given step procedure 
[25] with slight modifications, using for each frac- 
tion successive volumes of 20 ml HzO, 12 ml of 
5 mM sodium tetraborate and 60 mM ~monium 
formate, 28 ml of 5 mM sodium tetraborate and 
0.15 M ammonium formate, 24 ml of 0.1 M for- 
mic acid and 0.4 M ammonium formate, and 
24 ml of 0.1 M formic acid and 1 M ammonium 
formate; 4 ml of each fraction were taken for 
determination of radioactivity in Lumagel scin- 
tillation fluid. In each experiment, a pair of 
unlabeled slices was homogenized with t3H]Ins, 
[14C]IP~ and Ins-l [4,5-32P]-trisphosphate and 
treated as the experimental samples to check the 
accuracy of inositol phosphate separation. Results 
were expressed as cpm/lOO mg tissue wet wt (mean 
-+ SE) of triplicate samples. Significance of dif- 
ferences between groups was calculated by the 
paired t-test. Each experimental condition was 
reproduced in at least three different experiments 
with identical results. In each experiment, the reac- 
IP2 
LlCl LlCl I-ICI 1OmM 1lC I LlCl LICI IO mM 
Fig. 1. Effect of increasing concentrations of Cchol on IP accumulation over 20 min. The second column of the lefthand 
panel shows the action of Cchol 10W5 M in the absence of 10 mM LiCl. 
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Fig.2. Time course of IP accumulation in the presence of Cchol (10m5 M) and 10 mM LiCl. 
tivity of the slices to the agonists tested was check- 
ed by measuring protein iodination in control slices 
WI. 
3. RESULTS 
In dog thyroid slices, 10 mM LiCl had no dis- 
cernible effect on the basal levels of IP, but in- 
creased significantly the accumulation of IP3, 1P2 
NS 
. 
NS 
4000- 
and IPr induced by 10e5 M Cchol (fig.1). Cchol 
10m4 M and low5 M stimulated the generation of 
all three IPs (fig.1). Quantitatively, the accumula- 
tion was in the order: IP3 < IPz < IPr, but the fac- 
tors of stimulation were in the reverse order. When 
the pooled IP fractions were considered, the Cchol 
stimulation was significant at the lowest concentra- 
tion tested (lo-’ M) and showed a log linear in- 
crease with the agonist concentration. 
IP3 
LICI 1OmM LtCllOmM LICI 1OmM LICI IOmM LtCl IOmM LICI 10mM 
Fig.3. Inhibition by 5 x 10m6 M PDBu of the IP accumulation induced by Cchol, 5 x 10m6 and 10e5 M. (Incubation 
time 25 min, PDBu being added 5 min before Cchol.) 
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Fig.4. Effects of 20 mM NaF on IP accumulation (incubation time as indicated). 
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Fig.5. Lack of effects of 10 mu/ml TSH on IP accumulation over a 60 min time course. 
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The time course of a lo-’ M Cchol stimulation 
demonstrated a significant accumulation of IP3 
and IP2 after 2 min, and of IPr after 4 min (fig.2). 
For the next 20 min, the generation of the three 
IPs was parallel with no obvious precursor- 
product relationship. Atropine completely in- 
hibited the effects of Cchol (not shown). 
PDBu (5 x 10m6 M) had no effect by itself on the 
basal levels of IP, but, when added 5 min before 
the agonist, it inhibited nearly completely the ef- 
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feet of equimolar 5 x 10e6 M Cchol, and partially 
the action of 10m5 M Cchol (fig.3). 
Sodium fluoride (NaF, 20 mM) increased the 
generation of the three IP fractions, its effect being 
equivalent o that of 10e5 M Cchol at 20 min, and 
with a time course sustained for at least 60 min 
(fig.4). The stimulation exerted by 10e5 M Cchol 
as well as 20 mM NaF remained unchanged in the 
absence of extracellular Ca2+ (not shown). 
No effect of 10 mu/ml TSH on IP production 
could be detected over an hour incubation (fig.5). 
Varying TSH concentrations from 1 to 100 mu/ml 
and incubation times from 2 to 60 min could not 
reveal any significant change in any of the three IP 
fractions (not shown). 
4. DISCUSSION 
In the dog thyroid, Cchol through a muscarinic 
receptor stimulates protein iodination, glucose Ci 
oxidation, cGMP accumulation, and antagonizes 
the TSH-induced CAMP accumulation and hor- 
mone secretion [ 12,17,19,27-291. As these effects 
are reproduced by the ionophore A23187 in the 
presence of Ca2+, are inhibited in Ca2+ depleted 
cells and are accompanied by accelerated PI 
turnover, increased 45Ca2+ efflux and a raise in 
[Ca’+]i, it has been suggested that they result from 
a release of Ca2+ from intracellular stores conse- 
quent to PI hydrolysis [20,21,29,30]. The present 
data provide the first direct evidence that Cchol’s 
initial interaction with the thyroid membrane ac- 
tivates PIP2 hydrolysis, leading to IPJ accumula- 
tion and DAG release. As could be expected the 
increased IP production was blocked by atropine. 
The relationship between Cchol’s concentration 
and its effect on PIP2 hydrolysis is similar to that 
observed for the metabolic action of the 
cholinergic agonist [28,29]. The time course of IP 
generation in the presence of 10m5 M Cchol show- 
ed no early peak nor plateau phase for any of the 
IP fractions. This is compatible with the generally 
admitted sequential generation of IP in the order 
IPJ, IP2, IPr [2,24], as well as with a direct genera- 
tion of IP2 and IPr respectively from PIP and PI 
[31,32]. Considering the short half-life of Ins 
1,4,5-Ps, the linear increase of IP3 over at least 
20 min could suggest the generation of an 
unknown proportion of Ins 1,3,4-P3 as in the 
208 
parotid gland [6] or cerebral cortex [33]. 
NaF has long been known to exert various 
metabolic effects in the thyroid, some of them be- 
ing Ca2+ dependent like increased cGMP concen- 
trations, stimulated protein iodination and glucose 
Ci oxidation, while others are presumably related 
to inhibition of glycolysis: e.g. inhibition of TSH- 
induced CAMP accumulation and hormone secre- 
tion [9,27,28,34-361. The recent demonstration of 
a transducing G-protein coupling the hormonal 
receptor to the activation of phospholipase C 
[37,38] and of its stimulation by NaF in hepatic 
cells [39], neutrophils [40] and WRKr cell mem- 
branes [41], might explain the previous findings in 
the thyroid. The present data indeed show that 
NaF stimulates IP production in the thyroid over 
a prolonged time course, and without requiring the 
presence of extracellular Ca2+, which strongly sug- 
gest the validity of this model for the action of NaF 
on this tissue. 
Phorbol esters, probably through protein kinase 
C activation, exert some of the metabolic effects of 
Cchol in the dog thyroid (protein iodination, secre- 
tion), but they inhibit the initial steps of the Cchol- 
stimulated PI-Ca2+ cascade [19]. The present data 
extend these observations by showing that PDBu 
also inhibited the IP generation induced by Cchol. 
Similar observations have been reported with other 
tissues [42-441 and it has recently been suggested 
that phorbol ester action could result from in- 
creased IP3 degradation [45]. Such a mechanism of 
action is compatible with our data, but is insuffi- 
cient to explain the inhibition of IPr accumulation 
and of the increased PI turnover. In our dog 
thyroid system, other possible feedback targets of 
activated protein kinase C could thus be the 
muscarinic receptor, G-protein or phospholipase C 
complex [46-501. 
We were unable to detect any effect of TSH on 
IP production in our system. Such a negative result 
must be considered with caution. Indeed CAMP- 
independent increased PI turnover and 45Ca2+ ef- 
flux induced by TSH have repeatedly been 
documented by a number of authors over the last 
twenty years in the dog and pig thyroid [13-16,191. 
These effects have been called the A effects of TSH 
[18] by contrast to the B, CAMP-dependent effects. 
Moreover, TSH has been reported to increase 
[Ca2+]i in FRTL-5 thyroid cells [5 I], but not in dog 
thyroid cells [20,21]. Alternative hypotheses on 
Volume 210, number 2 FEBS LETTERS January 1987 
mechanisms compatible with such data will have to 
be investigated. 
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